⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ZTS

Zoetis Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

81.03USD

-0.9700 (-1.18%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ZTS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 81.03
P/E12.8
Dvd Ind Yld2.6%
P/B10.64
P/S3.5
Curr EV/T12M EBITDA10.1
Mkt Cap (USD)33.5B
Curr EV (USD)41.1B
2)

Per Share Data

EPS T12M6.06
DPS2.12
Bk Val Per Sh7.60
Rev/Sh22.78
Cash/Sh4.06
Curr Shares Out413.2M
FCF/Sh5.54
3)

Cash Flow Analysis

P/CF11.8
Curr P/FCF14.5
CF/NI1.1
Dvd P/O33.9%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales29.8%
Eff Interest Rate3.0%
4)

Growth Potential

Dil EPS 1Y Gr10.1%
Cap 1Y Gr9.9%
BPS 1Y Gr-26.6%
R&D To Sales—
Retention Rate66.1%
Rev 1Y Gr2.3%
FCF 1Y Gr-0.7%
Assets 1Y Gr8.8%
5)

Profitability

EBITDA4.1B
EBIT—
Operating Margin40.7%
Pretax Margin34.4%
Net Margin27.5%
ROA17.7%
ROE64.4%
ROC—
Asset Turnover0.64
6)

Structure

Current Ratio3.08
Quick Ratio1.58
Debt/Assets60.0%
Debt/Com Eq287.4%
Net Debt/EBITDA1.86
Tot Debt/Capital74.2%
Gross Margin71.5%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.